ArticleJournal of clinical pharmacology2022

A Model-Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A.

Koichiro Yoneyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.